Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2023 Jan 19;462:116381. doi: 10.1016/j.taap.2023.116381

Figure 3. Loss of SR-BI increases cyto/chemokine production in the airspace after oxPAPC exposure.

Figure 3.

Female WT or SR-BI−/− mice were exposed to oxPAPC via oropharyngeal (o.p.) aspiration and euthanized 4 h after exposure. Bronchoalveolar lavage (BAL) was collected for multiplex analysis of G-CSF, IL-6, CXCL1, IL-17A, and CCL2. *p<0.05, **p<0.01, ***p<0.001; n=5-13 per group.